| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 444,621 | 369,490 | 385,846 | 33,369 | | Cost of Revenue | 238,549 | 210,267 | 217,600 | 20,239 | | | Gross Profit | 206,072 | 159,223 | 168,246 | 13,130 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 195,563 | 159,979 | 216,376 | 809 | | Non Recurring |
-
| 8,689 | 1,388 | (85,235) | | Others |
-
|
-
|
-
| 61,759 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,509 | (756) | (48,130) | 35,797 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (128) | 1,322 | 76 | 6,810 | | Earnings Before Interest And Taxes | 10,381 | 566 | (48,054) | 42,607 | | Interest Expense | 3,236 | 3,227 | 3,215 | 1,629 | | Income Before Tax | 7,145 | (2,661) | (51,269) | 40,978 | | Income Tax Expense | 11,079 | 1,763 | 665 | (7,488) | | Minority Interest | (9,900) | (2,810) | (2,649) | 2,788 | | | | Net Income From Continuing Ops | (3,934) | (4,424) | (51,934) | 51,254 | | | Non-recurring Events | | Discontinued Operations | (295) | 23,332 | 21,627 | (57,287) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,129) | 16,098 | (32,956) | (6,033) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,129) | $16,098 | ($32,956) | ($6,033) |
|
0.51% Nasdaq 
0.14 (1.57%) 
Income Statement
